[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344666-105":59,"doc-detail-344666-en":129},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":122,"head_meta":124,"extra_data":126,"updated_unix":128},105,"en","sogug-multidisciplinary-expert-panel-consensus-on-updated-diagnosis-and-characterization-of-prostate-cancer-patients","SOGUG Multidisciplinary Expert Panel Consensus on Updated Diagnosis and Characterization of Prostate Cancer Patients","","A multidisciplinary group of prostate cancer care experts, organized through the ENFOCA2 project promoted by the Spanish Oncology Genitourinary Group (SOGUG), reviews and synthesizes up-to-date evidence on screening, diagnosis, imaging, risk-based management, and molecular characterization of prostate cancer patients. An MDT-based approach supports evidence-based care, shared decision-making, and treatment personalization aligned with patients’ values. Population screening using risk-stratified algorithms is emphasized, along with next-generation imaging (PSMA PET/CT and mpMRI). The review highlights improving mpMRI for extraprostatic extension, molecular imaging for metastatic staging, and adapting germline testing protocols to local practice. Genomic tools and ongoing validation of molecular biomarkers are stressed to enable more precise, individualized care across the disease spectrum.",{"@graph":69,"@context":121},[70,84,104],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sogug-multidisciplinary-expert-panel-consensus-on-updated-diagnosis-and-characterization-of-prostate-cancer-patients/344666/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":98,"encodingFormat":97,"isAccessibleForFree":99,"interactionStatistic":100},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sogug-multidisciplinary-expert-panel-consensus-on-updated-diagnosis-and-characterization-of-prostate-cancer-patients/344666.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-09-22",true,{"@type":101,"interactionType":102,"userInteractionCount":14},"InteractionCounter",{"@type":103},"ViewAction",{"@type":105,"mainEntity":106},"FAQPage",[107,113,117],{"name":108,"@type":109,"acceptedAnswer":110},"What is the main purpose of the SOGUG multidisciplinary consensus review?","Question",{"text":111,"@type":112},"To review and summarize current evidence on prostate cancer screening, diagnosis, imaging, risk-based approaches, and molecular characterization, including appropriate treatment considerations across disease stages.","Answer",{"name":114,"@type":109,"acceptedAnswer":115},"Why is a multidisciplinary team (MDT) approach emphasized?",{"text":116,"@type":112},"Because MDT care helps ensure patients receive evidence-based treatment, supports shared decision-making, and enables tailoring treatment to each patient’s values and preferences.",{"name":118,"@type":109,"acceptedAnswer":119},"What imaging strategies are highlighted as promising for prostate cancer diagnosis?",{"text":120,"@type":112},"Next-generation imaging, especially PSMA PET/CT (alone or with multiparametric MRI), is presented as having high diagnostic sensitivity, with specific focus on improving mpMRI for extraprostatic extension.","https://schema.org",{"og:url":83,"og:type":123,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":125,"canonical":83},"index,follow",{"doc_id":127,"site_id":62},344666,1790086467,{"code":4,"msg":5,"data":130},{"doc_id":127,"user_id":131,"nickname":92,"user_avatar":132,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":14,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":138,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Review  \nSOGUG Multidisciplinary Expert Panel Consensus on Updated Diagnosis and Characterization of Prostate Cancer Patients  \nEnrique Gallardo 1,*, Alfonso Gómez-de-Iturriaga 2, Jesús Muñoz-Rodríguez 3, Isabel Chirivella-González 4, Enrique González-Billababeita 5, Claudio Martínez-Ballesteros 6, María José Méndez-Vidal 7,  \nMercedes Mitjavila-Casanovas 8, Paula Pelechano Gómez 9, Aránzazu González-del-Alba 10 and Fernando López-Campos 11  \nReceived: 21 November 2025  \nRevised: 9 January 2026  \nAccepted: 16 January 2026  \nPublished: 20 January 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Oncology, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08202 Sabadell, Spain  \n2 Hospital Universitario de Cruces, Vizcaya, Biobizkaia Health Research Institute, Basque Country University (UPV/EHU), 48940 Santsoena, Spain  \n3 Department of Urology, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, 08202 Sabadell, Spain  \n4 Servicio Oncología Médica, Hospital Clínico Universitario, INCLIVA, Universidad de Valencia,  \n46010 Valencia, Spain  \n5 Hospital General Universitario 12 de Octubre, 28041 Madrid, Spain  \n6 Hospital Universitario Puerta de Hierro-Majadahonda, 28222 Madrid, Spain  \n7 Medical Oncology Department, Maimonides Institute for Biomedical Research of Córdoba (IMIBIC), Hospital Universitario Reina Sofía (HURS), 14004 Córdoba, Spain  \n8 JSº Medicina Nuclear, Hospital Universitario Puerta de Hierro-Majadahonda, 28222 Madrid, Spain  \n9 Servicio de Radiología, Fundación Instituto Valenciano de Oncología (IVO), 46009 Valencia, Spain  \n10 Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda,  \n28222 Madrid, Spain  \n11 Radiation Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Genesis Care Hospital Vithas La Milagrosa, 28010 Madrid, Spain  \n* Correspondence: [egallardo@tauli.cat](egallardo@tauli.cat)  \nSimple Summary  \nA group of experts in the care of patients with prostate cancer analyzed challenging aspects related to the diagnosis and management of the disease. These specialists reviewed evidence-based data reported in the literature, and after discussion together with their own experience, a narrative review was developed. The aim of the review was to provide updated information on diagnostic aspects and the most adequate treatment approaches for different stages of prostate cancer. Some important conclusions included: (1) the need to provide care within the framework of a multidisciplinary team; (2) the importance of tailoring treatment to individual preferences and values in a shared decision-making model, particularly regarding screening of prostate cancer; (3) the promising role of imaging techniques, such as prostate-specific membrane antigen/positron emission tomography/computed tomography due to their sensitivity; and (4) to focus further research in validation studies of molecular biomarkers for improving characterization of prostate cancer in clinical practice.  \nAbstract  \nA group of experts of different specialties involved in the care of prostate cancer (PCa) patients participated in the ENFOCA2 project, promoted by the Spanish Oncology Genitourinary Group (SOGUG), with the aim to review, discuss, and summarize current relevant aspects related to screening, diagnosis, imaging, risk-based approach, and molecular characterization of PCa. A multidisciplinary team (MDT) approach is essential to ensure that patients receive evidence-based care, promoting shared decision-making, and tailoring treatment to the patient’s unique values and preferences. Population-based screening  \nbased on risk-stratified algorithms is needed to overcome th","cbCaipiq1qKynsD6","https://ap.wps.com/l/cbCaipiq1qKynsD6","pdf",1244456,21,"English","# Simple Summary\n# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"What is the main purpose of the SOGUG multidisciplinary consensus review?\",\"answer\":\"To review and summarize current evidence on prostate cancer screening, diagnosis, imaging, risk-based approaches, and molecular characterization, including appropriate treatment considerations across disease stages.\"},{\"question\":\"Why is a multidisciplinary team (MDT) approach emphasized?\",\"answer\":\"Because MDT care helps ensure patients receive evidence-based treatment, supports shared decision-making, and enables tailoring treatment to each patient’s values and preferences.\"},{\"question\":\"What imaging strategies are highlighted as promising for prostate cancer diagnosis?\",\"answer\":\"Next-generation imaging, especially PSMA PET/CT (alone or with multiparametric MRI), is presented as having high diagnostic sensitivity, with specific focus on improving mpMRI for extraprostatic extension.\"}]","SOGUG Multidisciplinary Expert Panel Consensus on Updated Diagnosis and Characterization of Prostate Cancer Patients | PDF",1790054795,53]